Le Lézard
Classified in: Health
Subject: MAT

Dr. G. Hunt Neurohr Partners with the Exclusive Haute Beauty Network


DALLAS, March 27, 2020 /PRNewswire-PRWeb/ -- The Haute Beauty Network, well known for its exclusivity, and luxurious lifestyle, is privileged to present Dr. G. Hunt Neurohr as a leading Face expert representing the Dallas market and the newest addition to the Haute Living partnership.

Haute Beauty offers a prominent collective of leading doctors nationwide. The invitation-only exclusive network maintains elite as ever, with only two doctors in every market. This partnership allows Haute Beauty to connect its affluent readers with industry-leading doctors.

Visit Dr. Neurohr's Haute Beauty Profile: https://hauteliving.com/hautebeauty/member/dr-hunt-neurohr/

About Dr. Neurohr:

Dr. Neurohr is an American Board Certified Plastic Surgeon who has practiced in Dallas, Texas for over 25 years. He is dedicated to helping improve people's lives through Plastic and Reconstructive Surgery. Dr. Neurohr developed his interest in faces during his surgical training to treat cancers of the head and neck and immersed himself into the anatomical and surgical study of the region. The face is most challenging area to achieve surgical non-detectability; so, Dr. Neurohr further pursued his post-doctoral studies in facial aesthetic surgery with Dr. Bruce Connell at the Connell Clinic in Santa Ana, California. It was there that he realized he was adept at visualizing possible results for individual patients. If he could "see it," his hands could make it happen.

Dr. Neurohr and his family moved back to Dallas, Texas in 1990 due to the frequent Southern California earthquakes. He has built an exceptional aesthetic plastic surgery practice exclusively by "word of mouth". Dallas was a hot spot for developing facelift techniques in the 1990s and the term called "the Dallas look" was coined to describe the tight, pulled appearance of post-operative patients. These surgical techniques were designed to withstand extreme tension (the thought being that the tighter you could pull it, the longer it would last); however, surgical tension looks artificial in a facelift. Dr. Neurohr was well aware of this and avoided the trap. He developed an individualized SMAS facelift with fat grafting. Very few surgeons at the time believed that injectable fat grafts even worked, but Dr. Neurohr recognized how much of a natural improvement the technique produced in his patients. The quality of his results was unparalleled, and he quickly catapulted to the top tier of facial aesthetic surgeons in Dallas and in the state of Texas.

Dr. Neurohr constantly studies natural forms and shapes of living structures, always looking for applications which could further improve his surgical results. For instance, in the very unforgiving lower eyelid operation (blepharoplasty), he was one of the first to implement an array of stylized "canthopexy" procedures to preserve the inherent shape of the eye. He developed a "repair" operation that actually treated the lower eyelid fat bags like a hernia; therefore, restoring the proper spatial relationships of the lower eyelid and the cheek. He developed injectable fat grafting techniques which corrected the aging effects of "circles" under the lower eyelids. Dr. Neurohr was ahead of his time performing these avant-garde techniques.

As Dr. Neurohr became recognized for the quality of his work, he developed an international contingent of surgeons interested in understanding his ideas and methods, and was asked to lecture to plastic surgery groups in North America, Central America, and Europe about facelift techniques, eyelid surgery, surgical philosophy, and body contouring procedures. His expertise in identity preservation generates enthusiasm because it embodies the true art of plastic surgery. Dr. Neurohr has recently completed a chapter titled Avoiding Complication in Facelift Surgery in the textbook, Aesthetic Rejuvenation of the Face, published by Theime in May 2016.

Dr. Neurohr is devoted to his one and only wife of 39 years, Stephanie, and their eight children. He adeptly balances family responsibilities, his medical practice, and his personal health. His children and grandchildren help keep him young along with his deep faith, good nutrition, intense intermittent exercise, and the love of life. He operates a state-of-the-art surgical facility in friendly Dallas, TX certified by the AAAASF. There he personally consults with every patient, takes all his own photographs, and performs every detail of every surgical procedure, from the first marking to the very last stitch.

 

SOURCE Haute Beauty by Haute Living


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: